Back to News
Market Impact: 0.2
6 Biotech Stocks In Focus: Modular Medical, Galmed, Pro-Dex, Connect Biopharma & More
Source: Nasdaq
Regulation & LegislationHealthcare & BiotechCompany FundamentalsInvestor Sentiment & Positioning
Modular Medical climbed after-hours following FDA clearance for software enhancements to its Pivot tubeless patch pump, a positive regulatory milestone. Galmed Pharmaceuticals also gained after shareholders approved all five proposals at its AGM. Overall, the news is supportive but appears company-specific rather than market-wide.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
GLMD0.25
MODD0.55
More News
- Indonesian stocks plunge to six-year low as MSCI downgrade fears mount
- Nifty Bank Heavyweights HDFC, ICICI in Focus After Weekend Earnings
- China's CXMT sees shares drop over 6% as investors look past chipmaker's profit turnaround
- Asian stocks skid, Wall Street and bonds aided by oil slip
- Australia’s Cleanaway agrees to $6.5 bln EQT buyout bid; shares surge
- India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Build an Automated Research Process for a Fund
- Weekly Update: AI-Powered Report Editing, Investor Relations, and Enhanced Search